Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity

Shrock, Ellen, Fujimura, Eric, Kula, Tomasz, Timms, Richard T., Lee, I-Hsiu, Leng, Yumei, Robinson, Matthew L., Sie, Brandon M. +144 more·2020·Science

DOI 10.1126/science.abd4250

Cited by (677)

Items 101–200 of 677

Cytomegalovirus Latent Infection is Associated with an Increased Risk of COVID-19-Related Hospitalization
Cécile Alanio, Anurag Verma, Divij Mathew, Sigrid Gouma, Guanxiang Liang, Thomas G. Dunn, Derek A. Oldridge, JoEllen Weaver, Leticia Kuri-Cervantes, María Betina Pampena et al. · 2022 · The Journal of Infectious Diseases
Longitudinal Analysis of COVID-19 Patients Shows Age-Associated T Cell Changes Independent of Ongoing Ill-Health
Liam Townsend, Adam H. Dyer, Aifric Naughton, Rachel Kiersey, Dean Holden, Mary Gardiner, Joanne Dowds, Kate O’Brien, Ciarán Bannan, Parthiban Nadarajan et al. · 2021 · Frontiers in Immunology
Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers
S. Klompus, S. Leviatan, T. Vogl, R. Mazor, I. Kalka, Liat Stoler-Barak, Nachum Nathan, Ayelet Peres, L. Moss, A. Godneva et al. · 2021 · Science immunology
Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern
Courtney Voss, Sally Esmail, Xuguang Liu, Michael J. Knauer, Suzanne Z. Ackloo, Tomonori Kaneko, Lori E. Lowes, P.J. Stogios, Almagul Seitova, Ashley Hutchinson et al. · 2021 · JCI Insight
Relative Ratios of Human Seasonal Coronavirus Antibodies Predict the Efficiency of Cross-Neutralization of SARS-CoV-2 Spike Binding to ACE2
Yannick Galipeau, Vinayakumar Siragam, Geneviève Laroche, Erika Marion, Matthew Greig, Michaeline McGuinty, Ronald A. Booth, Yves Durocher, Miroslava Čuperlović‐Culf, Steffany A. L. Bennett et al. · 2021 · EBioMedicine
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications
Endeshaw Chekol Abebe, Tadesse Asmamaw Dejenie · 2023 · Frontiers in Immunology
Bringing immunofocusing into focus
Sriharshita Musunuri, Payton A. B. Weidenbacher, Peter S. Kim · 2024 · npj Vaccines
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells
Jennifer Chen, Ryan Dz-Wei Chow, Eric Song, Tianyang Mao, Benjamin Israelow, Kathy Kamath, Joel D. Bozekowski, Winston A. Haynes, Renata B. Filler, Bridget L. Menasché et al. · 2022 · Science Immunology
Surveilling and Tracking COVID-19 Patients Using a Portable Quantum Dot Smartphone Device
Yuwei Zhang, Ayden Malekjahani, Buddhisha N. Udugama, Pranav Kadhiresan, Hongmin Chen, Matthew Osborne, Max Franz, Mike Kucera, Simon W. Plenderleith, Lily Yip et al. · 2021 · Nano Letters
Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape
André E. Nel, Jeff F. Miller · 2021 · ACS Nano
Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2
Niclas Roxhed, Annika Bendes, Matilda Dale, Cecilia Mattsson, Leo Hanke, Tea Dodig‐Crnković, Murray B. Christian, Birthe Meineke, Simon J. Elsässer, Juni Andréll et al. · 2021 · Nature Communications
Does reactivation of cytomegalovirus contribute to severe COVID-19 disease?
Cecilia Söderberg‐Nauclér · 2021 · Immunity & Ageing
Impact of COVID-19 on Tuberculosis Case Detection and Treatment Outcomes in Sierra Leone
Sulaiman Lakoh, Darlinda F. Jiba, Mamadu Baldeh, Olukemi A Adekanmbi, Umu Barrie, Alhassan L. Seisay, Gibrilla Fadlu Deen, Robert A. Salata, George A. Yendewa · 2021 · Tropical Medicine and Infectious Disease
SARS-CoV-2 Epitope Mapping on Microarrays Highlights Strong Immune-Response to N Protein Region
Angelo Musicò, Roberto Frigerio, Alessandro Mussida, Luisa Barzon, Alessandro Sinigaglia, Silvia Riccetti, Federico Giovanni Gobbi, Chiara Piubelli, Greta Bergamaschi, Marcella Chiari et al. · 2021 · Vaccines
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19
Martin Dugas, Tanja Grote-Westrick, Uta Merle, Michaëla Fontenay, Andreas Emanuel Kremer, Frank Hanses, Richard Vollenberg, Eva Ulla Lorentzen, Shilpa Tiwari‐Heckler, Jérôme Duchemin et al. · 2021 · Journal of Clinical Virology
Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray
D. Camerini, A. Randall, Krista Trappl-Kimmons, Amit Oberai, C. Hung, J. Edgar, A. Shandling, Vu T. Huynh, A. Teng, G. Hermanson et al. · 2021 · medRxiv
Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs
Caitlin I. Stoddard, Jared Galloway, Helen Y. Chu, Mackenzie M. Shipley, Kevin Sung, Hannah L. Itell, Caitlin R. Wolf, Jennifer K. Logue, Ariana Magedson, Meghan E. Garrett et al. · 2021 · Cell Reports
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
Anna Schaffner, Lorenz Risch, Stefanie Aeschbacher, Corina Risch, Myriam C. Weber, Sarah L. Thiel, Katharina Jüngert, Michael Pichler, Kirsten Grossmann, Nadia Wohlwend et al. · 2020 · Journal of Clinical Medicine
Impaired neutralizing antibody response to COVID-19 mRNA vaccines in cancer patients
Cong Zeng, John Parker Evans, Sarah A. Reisinger, Jennifer Ann Woyach, Christina Liscynesky, Zeinab El Boghdadly, Mark P. Rubinstein, Karthik Chakravarthy, Linda J. Saif, Eugene M. Oltz et al. · 2021 · Cell & Bioscience
Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19
Philipp Jörrißen, Paula Schütz, Matthias Weiand, Richard Vollenberg, Inga Marie Schrempf, Kevin Ochs, Christopher Frömmel, Phil‐Robin Tepasse, Hartmut Schmidt, Andree Zibert · 2021 · Frontiers in Immunology
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies
Gabriela Athziri Sánchez‐Zuno, Mónica Guadalupe Matuz-Flores, Guillermo González-Estévez, Ferdinando Nicoletti, Francisco Javier Turrubiates‐Hernández, Katia Mangano, José Francisco Muñóz-Valle · 2021 · International Journal of Immunopathology and Pharmacology
Nowcasting epidemics of novel pathogens: lessons from COVID-19
Joseph Tsz Kei Wu, Kathy S. M. Leung, Tommy Tsan‐Yuk Lam, Michael Yuxuan Ni, Carlos King Ho Wong, Malik J. S. Peiris, Gabriel Matthew Leung · 2021 · Nature Medicine
SARS-CoV-2 Spike Protein Stabilized in the Closed State Induces Potent Neutralizing Responses
George Carnell, Katarzyna A. Ciazynska, David A. Wells, Xiaoli Xiong, Ernest T. Aguinam, Stephen H. McLaughlin, Donna L. Mallery, Soraya Ebrahimi, Lourdes Ceron‐Gutierrez, Benedikt Asbach et al. · 2021 · Journal of Virology
Infectious disease mRNA vaccines and a review on epitope prediction for vaccine design
Xinhui Cai, Jiao Jiao Li, Tao Liu, Oliver Brian, Jinyan Li · 2021 · Briefings in Functional Genomics
Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins
Yang Li, Zhaowei Xu, Qing Lei, Dan‐yun Lai, Hongyan Hou, He‐wei Jiang, Yun-xiao Zheng, Xuening Wang, Jiaoxiang Wu, Ming‐liang Ma et al. · 2021 · Cell Reports
SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population
Thomas J. Vogl, Sigal Leviatan, Eran Segal · 2021 · Cell Reports Medicine
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Ane Ogbe, Matthew J. Pace, Mustapha Bittaye, Timothy Tipoe, Sandra Adele, Jasmini Alagaratnam, Parvinder K. Aley, M. Azim Ansari, Anna Bara, Samantha Broadhead et al. · 2022 · JCI Insight
Allergenic food protein consumption is associated with systemic IgG antibody responses in non-allergic individuals
Sigal Leviatan, Thomas J. Vogl, Shelley Klompus, Iris N. Kalka, Adina Weinberger, Eran Segal · 2022 · Immunity
Phage display sequencing reveals that genetic, environmental, and intrinsic factors influence variation of human antibody epitope repertoire
Sergio Andreu‐Sánchez, Arno R. Bourgonje, Thomas J. Vogl, Alexander Kurilshikov, Sigal Leviatan, Angel Jonathan Ruiz-Moreno, Shixian Hu, Trishla Sinha, Arnau Vich Vila, Shelley Klompus et al. · 2023 · Immunity
Indiscriminate SARS-CoV-2 multivariant detection using magnetic nanoparticle-based electrochemical immunosensing
Ceren Durmus, Simge Balaban Hanoglu, Duygu Harmancı, Hichem Moulahoum, Kerem Tok, Faezeh Ghorbanizamani, Serdar Şanlı, Figen Zihnioğlu, Serap Evran, Candan Çiçek et al. · 2022 · Talanta
High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies
Meghan E. Garrett, Jared Galloway, Helen Y. Chu, Hannah L. Itell, Caitlin I. Stoddard, Caitlin R. Wolf, Jennifer K. Logue, Dylan McDonald, Haidyn Weight, Frederick A. Matsen IV et al. · 2021 · Cell
SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage
Mohsen Karami Fath, Abolfazl Jahangiri, Mahmoud Ganji, Fatemeh Sefid, Zahra Payandeh, Zahra Sadat Hashemi, Navid Pourzardosht, Anahita Hessami, Maysam Mard‐Soltani, Alireza Zakeri et al. · 2021 · Frontiers in Immunology
The past, current and future epidemiological dynamic of SARS-CoV-2
François Balloux, Cedric C.S. Tan, Leo Swadling, Damien Richard, Charlotte Jenner, Mala K. Maini, Lucy van Dorp · 2022 · Oxford Open Immunology
Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1
David J. Sullivan, Massimo Franchini, Jonathon W. Senefeld, Michael J. Joyner, Arturo Casadevall, Daniele Focosi · 2023 · Journal of General Virology
Lessons in antiviral immunity
Jennifer L. Hope, Linda M. Bradley · 2021 · Science
Cross-reactive antibody immunity against SARS-CoV-2 in children and adults
Elizabeth Fraley, Cas LeMaster, Dithi Banerjee, Santosh Khanal, Rangaraj Selvarangan, Todd Bradley · 2021 · Cellular and Molecular Immunology
Seropositivity in blood donors and pregnant women during the first year of SARS‐CoV‐2 transmission in Stockholm, Sweden
Xaquín Castro Dopico, Sandra Muschiol, Murray Christian, Leo Hanke, Daniel J. Sheward, Nastasiya F. Grinberg, Joanna Rorbach, Gordana Bogdanović, Gerald M. McInerney, Tobias Allander et al. · 2021 · Journal of Internal Medicine
Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses
Julia W. Angkeow, Daniel R. Monaco, Athena Chen, Thiagarajan Venkataraman, Sahana Jayaraman, Cristian Valencia, Brandon M. Sie, Thomas Liechti, Payam Noroozi Farhadi, Gabriela Funez-dePagnier et al. · 2022 · Immunity
Remembering seasonal coronaviruses
Jenna J. Guthmiller, Patrick C. Wilson · 2020 · Science
Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection
Michael J. Christie, Aaron Trent Irving, Samuel C. Forster, Benjamin J. Marsland, Philip M. Hansbro, Paul J. Hertzog, Claudia A. Nold‐Petry, Marcel F. Nold · 2021 · Science Immunology
Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike
Siriruk Changrob, Yanbin Fu, Jenna J. Guthmiller, Peter Halfmann, Lei Li, Christopher T. Stamper, Haley L. Dugan, Molly Accola, William Rehrauer, Nai-Ying Zheng et al. · 2021 · mBio
Antibody signatures in inflammatory bowel disease: current developments and future applications
Arno R. Bourgonje, Thomas J. Vogl, Eran Segal, Rinse Karel Weersma · 2022 · Trends in Molecular Medicine
Analysis of antibody binding specificities in twin and SNP-genotyped cohorts reveals that antiviral antibody epitope selection is a heritable trait
Thiagarajan Venkataraman, Cristian Valencia, Massimo Mangino, William R. Morgenlander, Steven J. Clipman, Thomas Liechti, Ana Valencia, Paraskevi Christofidou, Tim D. Spector, Mario Roederer et al. · 2022 · Immunity
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations
Elizabeth M. Anderson, Shuk Hang Li, Moses Awofolaju, Theresa Eilola, Eileen C. Goodwin, Marcus J. Bolton, Sigrid Gouma, Tomaz B. Manzoni, Philip D. Hicks, Rishi R. Goel et al. · 2022 · Cell Reports
Effects of vitamin D on macrophages and myeloid-derived suppressor cells (MDSCs) hyperinflammatory response in the lungs of COVID-19 patients
Małgorzata Kloc, Rafik Mark Ghobrial, Agnieszka Lipińska‐Opałka, Agata Wawrzyniak, Robert Zdanowski, Bolesław Kalicki, Jacek Z. Kubiak · 2020 · Cellular Immunology
Impact of computational approaches in the fight against COVID-19: an AI guided review of 17 000 studies
Francesco Napolitano, Xiaopeng Xu, Xin Gao · 2021 · Briefings in Bioinformatics
Omics Data and Data Representations for Deep Learning-Based Predictive Modeling
Stefanos Tsimenidis, Εleni Vrochidou, George A. Papakostas · 2022 · International Journal of Molecular Sciences
Systemic antibody responses against human microbiota flagellins are overrepresented in chronic fatigue syndrome patients
Thomas J. Vogl, Iris N. Kalka, Shelley Klompus, Sigal Leviatan, Adina Weinberger, Eran Segal · 2022 · Science Advances
ORF10–Cullin-2–ZYG11B complex is not required for SARS-CoV-2 infection
Elijah L. Mena, Callie J. Donahue, Laura Pontano Vaites, Jie Li, Gergely Róna, Colin O’Leary, Luca Lignitto, Bearach Miwatani-Minter, João A. Paulo, Avantika Dhabaria et al. · 2021 · Proceedings of the National Academy of Sciences
Dye-Loaded Polymersome-Based Lateral Flow Assay: Rational Design of a COVID-19 Testing Platform by Repurposing SARS-CoV-2 Antibody Cocktail and Antigens Obtained from Positive Human Samples
Faezeh Ghorbanizamani, Kerem Tok, Hichem Moulahoum, Duygu Harmancı, Simge Balaban Hanoglu, Ceren Durmus, Figen Zihnioğlu, Serap Evran, Candan Çiçek, Ruchan Yazan Sertoz et al. · 2021 · ACS Sensors
VirScan: High-throughput Profiling of Antiviral Antibody Epitopes
Ellen L. Shrock, Christine L. Shrock, Stephen Joseph Elledge · 2022 · BIO-PROTOCOL
Immunogenicity and protectivity of the peptide vaccine against SARS-CoV-2
Alexander B. Ryzhikov, Evgenii А. Ryzhikov, Marina P. Bogryantseva, Е. Д. Даниленко, Иматдинов Ильназ Рамисович, Нечаева Елена Августовна, Oleg V. Pyankov, Olga G. Pyankova, Ivan M. Susloparov, Oleg Svyatoslavovich Taranov et al. · 2021 · Annals of the Russian academy of medical sciences
Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles
Aniuska Becerra‐Artiles, J. Mauricio Calvo‐Calle, Mary Dawn T. Co, Padma Pandurang Nanaware, John Cruz, Grant C. Weaver, Liying Lu, Catherine Suzanne Forconi, Robert W. Finberg, Ann Marie Moormann et al. · 2022 · Cell Reports
Immunoinformatics prediction of overlapping CD8+ T-cell, IFN-γ and IL-4 inducer CD4+ T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2)
Abiodun Joseph Fatoba, Leah Maharaj, Victoria T. Adeleke, Moses Okpeku, Adebayo A. Adeniyi, Matthew Adekunle Adeleke · 2021 · Vaccine
A SARS‐CoV‐2 Neutralization Assay Using Single Molecule Arrays
Tal Gilboa, Limor Cohen, Chi‐An Cheng, Roey Lazarovits, Augusta Uwamanzu‐Nna, Isaac Han, Kettner Griswold, Nick Barry, David B. Thompson, Richie E. Kohman et al. · 2021 · Angewandte Chemie International Edition
Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin
Jernej Pušnik, Jasmin Zorn, Werner Otoniel Monzon‐Posadas, Kathrin Peters, Emmanuil Osypchuk, Sabine Blaschke, Hendrik Streeck · 2024 · Nature Communications
Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model
Denicar Lina Nascimento Fabris Maeda, Debin Tian, Hanna Yu, Nakul Dar, Vignesh Rajasekaran, Sarah Meng, Hassan M. Mahsoub, Harini Sooryanarain, Bo Wang, Connie Lynn Heffron et al. · 2021 · Proceedings of the National Academy of Sciences
Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration
Sigrid Gouma, Madison E. Weirick, Marcus J. Bolton, Claudia P. Arevalo, Eileen C. Goodwin, Elizabeth M. Anderson, Christopher M. McAllister, Shannon R. Christensen, Debora Dunbar, Danielle Fiore et al. · 2021 · JCI Insight
Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients
Linlin Cheng, Xiaomei Zhang, Yu Chen, Dan Wang, Dong Zhang, Songxin Yan, Hongye Wang, Meng Xiao, Te Liang, Haolong Li et al. · 2021 · Signal Transduction and Targeted Therapy
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod
Lil Meyer‐Arndt, Julian Braun, Florent Fauchère, Kanika Vanshylla, Lucie Loyal, Larissa Henze, Beate Kruse, Manuela Dingeldey, Karsten Jürchott, Maike Mangold et al. · 2022 · Journal of Neurology Neurosurgery & Psychiatry
Aptamers for Detection and Diagnostics (ADD): Can mobile systems process optical data from aptamer sensors to identify molecules indicating presence of SARS-CoV-2 virus? Should healthcare explore aptamers as drugs for prevention as well as its use as adjuvants with antibodies and vaccines?
Shoumen Datta · 2020 · ChemRxiv
Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques following SARS-CoV-2 Vaccination and Infection
Catherine Jacob-Dolan, Jared E. Feldman, Katherine McMahan, Jingyou Yu, Roland C. Zahn, Frank Wegmann, Hanneke Schuitemaker, Aaron G. Schmidt, Dan H. Barouch · 2021 · Journal of Virology
Bat virome research: the past, the present and the future
Chee Wah Tan, Xing‐Lou Yang, Danielle E. Anderson, Lin‐Fa Wang · 2021 · Current Opinion in Virology
Neutralizing Antibody Responses to SARS-CoV-2 in Recovered COVID-19 Patients Are Variable and Correlate With Disease Severity and Receptor-Binding Domain Recognition
Agnieszka Katarzyna Macioła, Massimo La Raja, Monia Pacenti, Cristiano Salata, Giustina De Silvestro, Antonio Rosato, Giulia Pasqual · 2022 · Frontiers in Immunology
Comprehensive profiling of antibody responses to the human anellome using programmable phage display
Thiagarajan Venkataraman, Harish Swaminathan, Cesar Arze, Sarah Melissa P Jacobo, Agamoni Bhattacharyya, Tyler David, Dhananjay M. Nawandar, Simon Delagrave, Vinidhra Mani, Nathan L. Yozwiak et al. · 2022 · Cell Reports
Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen
Min Jiang, Gaiping Zhang, Hongliang Liu, Peiyang Ding, Yunchao Liu, Yuanyuan Tian, Yanwei Wang, Aiping Wang · 2021 · Frontiers in Immunology
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection
Meghan E. Garrett, Jared G. Galloway, Caitlin Wolf, Jennifer K. Logue, Nicholas Franko, Helen Y. Chu, Frederick A. Matsen IV, Julie Overbaugh · 2022 · eLife
Diversity of Coronaviruses with Particular Attention to the Interspecies Transmission of SARS-CoV-2
Awad Ali Shehata, Youssef A. Attia, Md. Tanvir Rahman, Shereen Basiouni, Hesham Rushdey El-Seedi, Esam I. Azhar, Asmaa Fahmy Khafaga, Hafez M. Hafez · 2022 · Animals
Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2
Worarat Chaisawangwong, Hanzhi Wang, Theodore S. Kouo, Sebastian F. Salathe, Ariel Isser, Joan Glick Bieler, Maya L. Zhang, Natalie K. Livingston, Shuyi Li, Joseph J. Horowitz et al. · 2022 · JCI Insight
Epitope Diversity and SARS-CoV-2 Variants Neutralizing Capacity of SARS-CoV-2 Hyperimmune Intravenous Immunoglobulins for Treatment of COVID-19
Juanjie Tang, Youri Lee, Supriya Ravichandran, Gabrielle Grubbs, Chang Huang, Charles B. Stauft, Tony T. Wang, Basil Golding, Hana Golding, Surender Khurana · 2021 · iScience
Cross-Reactive Immune Responses toward the Common Cold Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Mini-Review and a Murine Study
Robert E. Sealy, Julia L. Hurwitz · 2021 · Microorganisms
Longitudinal analysis of antibody decay in convalescent COVID-19 patients
Weiming Xia, Mingfei Li, Ying Wang, Lewis E. Kazis, Kim Berlo, Noureddine Melikechi, Gregory R. Chiklis · 2021 · Scientific Reports
Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant
Laura T. Gray, Michal M. Raczy, Priscilla S. Briquez, Tiffany M. Marchell, Aaron T. Alpar, Rachel P. Wallace, Lisa R. Volpatti, Maria Stella Sasso, Shijie Cao, Mindy Nguyen et al. · 2021 · Biomaterials
Design Principles of Nanosensors for Multiplex Detection of Contaminants in Food
Yang Zhang, Shipeng Gao, Hongbin Li, Tianxi Yang, Kaiyi Zheng, Zhing Ming Guo, Jiyong Shi, Xiaowei Huang, Xiaobo Zou, Pierre Picchetti et al. · 2025 · Small
Memory B cell diversity: insights for optimized vaccine design
Joshua J.C. McGrath, Lei Li, Patrick C. Wilson · 2022 · Trends in Immunology
Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2
Kim Tien Ng, Nur Khairiah Mohd-Ismail, Yee‐Joo Tan · 2021 · Vaccines
The presence of serum anti‐SARS‐CoV‐2 IgA appears to protect primary health care workers from COVID‐19
Viktoria Hennings, Karolina Thörn, Sofie Albinsson, Christine Lingblom, Kerstin Malm Andersson, Christer Andersson, Katarina Järbur, Rille Pullerits, Manja Idorn, Søren R. Paludan et al. · 2022 · European Journal of Immunology
Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity
Liqiu Jia, Shufeng Weng, Jing Wu, Xiangxiang Tian, Yifan Zhang, Xuyang Wang, Jing Wang, Dongmei Yan, Wanhai Wang, Fang Fang et al. · 2022 · Gut Microbes
Promises and challenges of mucosal COVID-19 vaccines
Abhay P. S. Rathore, Ashley L. St. John · 2023 · Vaccine
Previous viral symptoms and individual mothers influenced the leveled duration of human milk antibodies cross-reactive to S1 and S2 subunits from SARS-CoV-2, HCoV-229E, and HCoV-OC43
Véronique Demers‐Mathieu, Ciera DaPra, Gabrielle B. Mathijssen, Elena Taggart Medo · 2021 · Journal of Perinatology
Immune profiling of COVID-19: preliminary findings and implications for the pandemic
Holden Terry Maecker · 2021 · Journal for ImmunoTherapy of Cancer
Lipid and Nucleocapsid N-Protein Accumulation in COVID-19 Patient Lung and Infected Cells
Anita E. Grootemaat, Sanne van der Niet, Edwin R. Scholl, Eva Roos, Bernadette Schurink, Marianna Bugiani, Sara Miller, Per W. B. Larsen, Jeannette E. Pankras, Eric A. Reits et al. · 2022 · Microbiology Spectrum
Autoantibodies against apolipoprotein A‐1 after COVID‐19 predict symptoms persistence
Arnaud Grégoire L’Huillier, Sabrina Pagano, Stéphanie Baggio, Benjamin Meyer, Diego O. Andrey, Mayssam Nehme, Idris Guessous, Christiane Sigrid Eberhardt, Angela Csaki Huttner, Klara Maria Posfay-Barbe et al. · 2022 · European Journal of Clinical Investigation
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
Raju Sunagar, Amit Singh, Sudeep Kumar · 2023 · Vaccines
Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients
Jennifer M. Sasson, Joseph J. Campo, Rebecca M. Carpenter, Mary K. Young, Arlo Z. Randall, Krista Trappl, Amit Oberai, Christopher Hung, Joshua M. Edgar, Andy Teng et al. · 2021 · mBio
A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG
Fang Fang Li, Aaron C. Liu, Ebrima Gibbs, Guadalein Tanunliong, Ana Citlali Marquez, Soren M. Gantt, Hans Frykman, Mel Krajden, Muhammad Golam Morshed, Natalie Prystajecky et al. · 2021 · Journal of Clinical Virology
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses
Jan Lawrenz, Qinya Xie, Fabian Zech, Tatjana Weil, Alina Seidel, Daniela Krnavek, Lia van der Hoek, Jan Münch, Janis A. Müller, Frank Kirchhoff · 2022 · Clinical Infectious Diseases
Repertoires of SARS-CoV-2 epitopes targeted by antibodies vary according to severity of COVID-19
David J. Gregory, Augustin Vannier, Akiro H. Duey, Tyler J. Roady, Richard Kuo Dzeng, Maia Pavlovic, Michael H. Chapin, Sonia Mukherjee, Hannah Wilmot, Nic Chronos et al. · 2022 · Virulence
Antibody-mediated immunity to SARS-CoV-2 spike
John M. Errico, Lucas J. Adams, Daved H. Fremont · 2022 · Advances in immunology
The S2 subunit of spike encodes diverse targets for functional antibody responses to SARS-CoV-2
Jamie Guenthoer, Meghan E. Garrett, Michelle Lilly, Delphine Depierreux, Felicitas Ruiz, Margaret Chi, Caitlin I. Stoddard, Vrasha Chohan, Zak A. Yaffe, Kevin Sung et al. · 2024 · PLoS Pathogens
Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score
Sanjana R. Sen, Emily C. Sanders, Kristin Gabriel, B.M. Miller, Hariny M. Isoda, Gabriela S. Salcedo, Jason E. Garrido, Rebekah P. Dyer, Rie Nakajima, Aarti Jain et al. · 2021 · mSphere
SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control study
Antoine Lewin, Roseline Therrien, Gaston De Serres, Yves Grégoire, Josée Perreault, Mathieu Drouin, Marie‐Josée Fournier, Tony Tremblay, Julie Beaudoin, Guillaume Beaudoin-Bussières et al. · 2021 · Canadian Journal of Public Health
Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants
Yoshitomo Morinaga, Hideki Tani, Yasushi Terasaki, Satoshi Nomura, Hitoshi Kawasuji, Takahisa Shimada, Emiko Igarashi, Yumiko Saga, Yoshihiro Yoshida, Rei Yasukochi et al. · 2021 · Microbiology Spectrum
Age-Dependent Reduction in Neutralization against Alpha and Beta Variants of BNT162b2 SARS-CoV-2 Vaccine-Induced Immunity
Hitoshi Kawasuji, Yoshitomo Morinaga, Hideki Tani, Yumiko Saga, Makito Kaneda, Yushi Murai, Akitoshi Ueno, Yuki Miyajima, Yasutaka Fukui, Kentaro Nagaoka et al. · 2021 · Microbiology Spectrum
Phage ImmunoPrecipitation Sequencing (PhIP-Seq): The Promise of High Throughput Serology
Charles Kevin Tiu, Feng Zhu, Lin‐Fa Wang, Ruklanthi de Alwis · 2022 · Pathogens
Autoimmune Effect of Antibodies against the SARS-CoV-2 Nucleoprotein
Daria S. Matyushkina, Varvara Shokina, Polina Tikhonova, Valentin A. Manuvera, Dmitriy A. Shirokov, Daria D. Kharlampieva, В. Н. Лазарев, Anna M. Varizhuk, Tatiana Vedekhina, Alexander Vladimirovich Pavlenko et al. · 2022 · Viruses
SARS‐CoV‐2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design
Faezeh Maghsood, Ahmad Ghorbani Vanan, Hamidreza Yadegari, Forough Golsaz‐Shirazi, Mohammad Mehdi Amiri, Fazel Shokri · 2023 · Reviews in Medical Virology
Severe COVID-19 patients display a back boost of seasonal coronavirus-specific antibodies
Brenda M. Westerhuis, Muriel Aguilar-Bretones, Matthijs P. Raadsen, Erwin de Bruin, Nisreen M.A. Okba, Bart L. Haagmans, Thomas Langerak, Henrik Endeman, Johannes P. C. van den Akker, Diederik A M P J Gommers et al. · 2020 · medRxiv
Serodynamics: A primer and synthetic review of methods for epidemiological inference using serological data
James A. Hay, Isobel Routledge, Saki Takahashi · 2024 · Epidemics
High‐throughput detection of antibodies targeting the SARS‐CoV ‐2 Spike in longitudinal convalescent plasma samples
Sai Priya Anand, Jérémie Prévost, Jonathan Richard, Josée Perreault, Tony Tremblay, Mathieu Drouin, Marie‐Josée Fournier, Antoine Lewin, Renée Bazin, Andrés Finzi · 2021 · Transfusion